Andere talen Healios K.K.

Aandelen

4593

JP3835100003

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
149 ^JPY	+0,68%		+1,36%	-9,70%

09/04	Healios K.K. gaat een gezamenlijke onderzoeksovereenkomst aan met AND Medical Group	CI
03/04	Healios K.K. (TSE:4593) heeft de overname afgerond van vrijwel alle activa van Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA en ReGenesys, LLC .	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	10/04
Healios K.K. Enters into Joint Research Agreement with AND Medical Group	09/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data	26/02
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation	26/02
Healios K.K. announced that it has received ¥2.2600715 billion in funding	09/02
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan	02/02
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding	25/01
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment	18/01
Japanese Shares Finish Lower After Key Economic Data	18/01
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan	18/01
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Healios Secures LOI on Joint Research with AND	17/01
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research	16/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Healios, Nobelpharma in Talks for Stem Cell Therapy Alliance for ARDS	28/12
Healios Invests in Arktus Therapeutics at Undisclosed Amount	26/12
Healios K.K. (TSE : 4593) agreed to acquire an unknown minority stake in Arktus Therapeutics Co., Ltd.	22/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Healios K.K.

Aandelen

4593

JP3835100003

Andere talen

Filters